Khandaker Shehneela
Bangladesh
Posters & Accepted Abstracts: J Nurs Care
Introduction & Aim: Chromosomal anomalies/aneuploidy (such as trisomy 21/down syndrome) is one of the
leading causes of perinatal mortality and developmental abnormality. This study was designed to determine
the diagnostic accuracy of non-invasive integrated approach (maternal age and serum biochemistry+fetal
USG) in detecting fetal chromosomal abnormality in first trimester of pregnancy among Bangladeshi women.
Methods: This prospective observational study was conducted at Maternal-Fetal Medicine (MFM) Obstetrics
OPD, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka. Total 76 women at 11-13+6 weeks,
carrying singleton fetus were selected. Integrated non-invasive screening methods using combination
of Maternal Age (MA), free β-hCG, PAPP-A and fetal USG based measurement of Nuchal Translucency
(NT)+Nasal Bone (NB)+Tricuspid Regurgitation (TR)+ductus venosus flow were performed. Risk assessment
for aneuploidy was done by using feto-maternal module of the Prisca software (version 5.0) according to the
FMF (London) algorithm. Cut-off risk value of 1 in 300 was considered. Data was analyzed by computer with
the help of SPSS 17.0.
Result: 5% women become screen positive and 95% were screen negative. Three chromosomal abnormalities
were identified including two cases of trisomy 21 and single case of Turner syndrome. The sensitivity and false
negative rates for detection of trisomy 21 was 100% and 0% respectively. And overall, sensitivity, false negative
rates, specificity and false positive rates of the integrated risk assessment tool for detection of all aneuploidy
was 66.7%, 33.3%, 98.6% and 1.4%, respectively.
Conclusion: Non-invasive integrated screening method can detect aneuploidy up to 100% while reducing the
false-positive rate by 0%, may lead to decreased number of invasive tests.
E-mail: shehneelasumi@gmail.com
Journal of Nursing & Care received 4230 citations as per Google Scholar report